Comprehensive test portfolio for Alzheimer’s disease
Support for diagnosis and therapy decision: Our test systems allow not only the determination of the biomarkers amyloid beta, total tau and pTau but now also enable APOE genotyping, which can provide information about the potential risk of side effects under antibody treatment.
more